Published in Neurology on September 23, 2008
Advances in the genetics of glioblastoma: are we reaching critical mass? Nat Rev Neurol (2009) 1.48
Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site. BMC Cancer (2012) 1.18
Inherited predisposition to glioma. Neuro Oncol (2009) 0.99
Discriminating risk and resilience endophenotypes from lifetime illness effects in familial major depressive disorder. JAMA Psychiatry (2014) 0.88
Increased Default Mode Network Connectivity in Individuals at High Familial Risk for Depression. Neuropsychopharmacology (2015) 0.85
Familial risks in nervous system tumours: joint Nordic study. Br J Cancer (2010) 0.84
Association study of xenobiotic detoxication and repair genes with malignant brain tumors in children. Acta Naturae (2010) 0.78
Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas. J Exp Clin Cancer Res (2011) 0.78
Familial glioblastoma: A case report of glioblastoma in two brothers and review of literature. Surg Neurol Int (2011) 0.77
New insights into the genetics of glioblastoma multiforme by familial exome sequencing. Oncotarget (2015) 0.77
SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin. Iran J Pharm Res (2016) 0.75
Nationwide registry-based analysis of cancer clustering detects strong familial occurrence of Kaposi sarcoma. PLoS One (2013) 0.75
A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers. Cancer Genomics Proteomics (2016) 0.75
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst (1994) 6.27
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet (1994) 3.05
Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol (2006) 2.51
The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer (1991) 1.94
Familiality of cancer in Utah. Cancer Res (1994) 1.80
Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J (2006) 1.60
A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg (2003) 1.60
Brain tumor-polyposis syndrome: two genetic diseases? J Clin Oncol (1997) 1.27
Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer (1997) 1.26
Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer (2003) 1.21
Genetic epidemiology of childhood brain tumors. Genet Epidemiol (1991) 1.14
Multiple endocrine neoplasia type 1. J Surg Oncol (2005) 1.11
Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer (1999) 1.08
Genetic epidemiology of glioma. Br J Cancer (2001) 1.03
Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation (2004) 1.02
Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control (2001) 0.99
Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology (2002) 0.99
Segregation analysis of cancer in families of glioma patients. Genet Epidemiol (2001) 0.98
Genetics in intracranial tumours. Acta Genet Stat Med (1957) 0.96
Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev (2002) 0.92
Familial associations between cancer sites. Comput Biomed Res (1999) 0.92
Mormon demographic history I. Nuptiality and fertility of once-married couples. Popul Stud (Camb) (1978) 0.91
Hereditary tumor syndromes of the nervous system: overview and rare syndromes. Brain Pathol (1995) 0.88
Central nervous system cancers in first-degree relatives and spouses. Cancer Invest (1999) 0.88
Glioblastoma multiforme in three family members, including a case of true multicentricity. J Neurol (1986) 0.83
Gliomas in families. Can J Neurol Sci (1992) 0.81
Familial clustering of malignant astrocytomas. J Neurooncol (1990) 0.80
Familial factors associated with malignant gliomas. Genet Epidemiol (1990) 0.80
Familial gliomas: report of four families, with chromosome studies. Neurosurgery (1982) 0.79
Von Hippel-Lindau disease--a rare disease important to recognize. Onkologie (2005) 0.77
Turcot's syndrome. Flow cytometric analysis. Cancer (1991) 0.77
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet (2011) 2.29
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet (2012) 2.18
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet (2005) 1.96
Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study. Arch Neurol (2012) 1.87
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet (2006) 1.70
Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology (2009) 1.61
Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J (2006) 1.60
Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev (2009) 1.60
Evidence for an inherited predisposition to lumbar disc disease. J Bone Joint Surg Am (2011) 1.53
Longitudinal assessment of the nevus phenotype in a melanoma kindred. J Invest Dermatol (2004) 1.44
Empiric evidence for a genetic contribution to predisposition to surgical site infection. Wound Repair Regen (2013) 1.43
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.29
A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med (2007) 1.25
Evidence for an inherited predisposition contributing to the risk for rotator cuff disease. J Bone Joint Surg Am (2009) 1.21
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet (2007) 1.20
Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer (2005) 1.20
Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site. BMC Cancer (2012) 1.18
Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol (2006) 1.17
Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21. Am J Hum Genet (2009) 1.16
Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Cancer Res (2006) 1.16
Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med (2011) 1.13
A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet (2011) 1.10
Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev (2009) 1.10
Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet (2005) 1.08
A comprehensive survey of cancer risks in extended families. Genet Med (2012) 1.06
Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol (2006) 1.05
Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol (2005) 1.04
Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation (2004) 1.02
A population-based description of familial clustering of pancreatic cancer. Clin Gastroenterol Hepatol (2010) 0.97
Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genet Epidemiol (2005) 0.96
Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb. Prostate (2007) 0.95
Familial myeloma. N Engl J Med (2008) 0.94
Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 0.94
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Hum Genet (2013) 0.93
Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study. Cancer Epidemiol Biomarkers Prev (2009) 0.93
Familial clustering of endometrial cancer in a well-defined population. Gynecol Oncol (2011) 0.92
Significant evidence for linkage to chromosome 5q13 in a genome-wide scan for asthma in an extended pedigree resource. Eur J Hum Genet (2008) 0.90
Confirmation of chromosome 7q11 locus for predisposition to intracranial aneurysm. Hum Genet (2003) 0.90
A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol (2007) 0.90
A role for XRCC4 in age at diagnosis and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 0.90
Evidence for a heritable predisposition to Chronic Fatigue Syndrome. BMC Neurol (2011) 0.90
Evidence of an inherited predisposition for cervical spondylotic myelopathy. Spine (Phila Pa 1976) (2012) 0.89
Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands. J Invest Dermatol (2006) 0.88
Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate (2010) 0.88
High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene. Ann Hum Genet (2006) 0.85
Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease. Am Heart J (2010) 0.83
A population-based analysis of clustering identifies a strong genetic contribution to lethal prostate cancer. Front Genet (2013) 0.83
Dissecting the genetic etiology of major depressive disorder using linkage analysis. Trends Mol Med (2005) 0.83
Examination of ELN as a candidate gene in the Utah intracranial aneurysm pedigrees. Stroke (2005) 0.82
The familiality of pelvic organ prolapse in the Utah Population Database. Int Urogynecol J (2012) 0.82
Failure to detect differences in proliferation status of nevi from CDKN2A mutation carriers and non-carriers. J Invest Dermatol (2002) 0.81
Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. PLoS One (2013) 0.81
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate (2011) 0.81
Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study. PLoS One (2013) 0.81
Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Dermatol (2007) 0.80
A genome wide linkage scan for dizygotic twinning in 525 families of mothers of dizygotic twins. Hum Reprod (2010) 0.80
Co-prevalence of other tumors in patients harboring pituitary tumors. J Neurosurg (2014) 0.80
Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes. Cancer Epidemiol Biomarkers Prev (2011) 0.80
Extracting disease risk profiles from expression data for linkage analysis: application to prostate cancer. BMC Proc (2007) 0.79
How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med (2011) 0.79
Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree. J Invest Dermatol (2008) 0.79
Utah Population Database: a tool to study the hereditary element of nonsyndromic neurosurgical diseases. Neurosurg Focus (2010) 0.78
Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation. J Invest Dermatol (2005) 0.78
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet (2012) 0.76
A parallel genetic algorithm to discover patterns in genetic markers that indicate predisposition to multifactorial disease. Comput Biol Med (2008) 0.75
No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees. BMC Res Notes (2009) 0.75
Pairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees. BMC Genomics (2012) 0.75
The impact of family history on the risk of colorectal neoplasia: don't change the guidelines just yet! Dig Dis Sci (2012) 0.75
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun (2015) 0.75